This was confirmed in two additional cohorts, a 960-sample invasive breast cancer cohort which showed that high BAALC expression was significantly associated with worse disease-free survival (Figure 2C; p = 0.0487) (33), and in an 821-sample untreated breast cancer cohort demonstrating that high BAALC expression was significantly associated with worse DMFS (Figure 2D; p = 0.03622). The gene discussed is BAALC; the disease is breast carcinoma.